MedPath

Untersuchung Zur Erfassung Und Kontrolle Der Lebensqualität Unter Einer Therapie Mit Pollinex Quattro Bei Heuschnupfen

Completed
Conditions
Rhinitis, Allergic, Seasonal
Registration Number
NCT03014661
Lead Sponsor
Universität des Saarlandes
Brief Summary

Questionnaire to measure and control the quality of life of patients with hay fever who are treated or were treated with Pollinex quattro

Detailed Description

Questionnaire including 19 questions concerning the Quality of life of patients with hayfeyer under or after therapy with a specific immuntherapy with Pollinex quattro

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
58
Inclusion Criteria
  • Pollinosis/seasonal Rhinitis based on an allergy against birch/alder/Hazel pollen OR grass/rye pollen OR mugwort
  • Therapy with Polinex quattro
Exclusion Criteria
  • Age <18 years.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Quality of life questionnaire (DLQI)during year one, year two, year three of therapy or within 6 months after completion of therapy
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Saarland University Hospital. Department of Dermatology

🇩🇪

Homburg, Saarland, Germany

Saarland University Hospital. Department of Dermatology
🇩🇪Homburg, Saarland, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.